Of special interest is the ability of IFN-β to reduce production of tumor necrosis factor α (TNF-α), interleukin (IL)-1β, and IL-6, which are all key cytokines in the pathogenesis of RA. This evidence concerns the gene IFNB1 and rheumatoid arthritis.